Health care costs

Sen. Bernie Sanders, I-Vt., introduces the Medicare for All Act of 2019, on Capitol Hill in Washington, Wednesday, April 10, 2019. (AP Photo/Manuel Balce Ceneta)
April 10, 2019 - 3:43 pm
WASHINGTON (AP) — Sen. Bernie Sanders of Vermont unveiled a revamped version of his "Medicare for All" plan on Wednesday, shaking up the 2020 presidential race by renewing his call for replacing job-based and private health insurance with a government plan that guarantees coverage for all. "It is...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More
Sen. Bernie Sanders speaks during the National Action Network Convention in New York, Friday, April 5, 2019. (AP Photo/Seth Wenig)
April 06, 2019 - 8:49 pm
BURLINGTON, Iowa (AP) — They became notable presidential candidates in Iowa after narrow losses that nonetheless put them on the national political stage. They're competing for some of the same young voters. And this weekend, they've been driving around this first-in-the-nation caucus state...
Read More
FILE- In this June 25, 2018, file photo shows a Walgreens store in Peoria, Ariz. Walgreens Boots Alliance, Inc. reports financial earns on Tuesday, April 2, 2019. (AP Photo/Ross D. Franklin, File)
April 02, 2019 - 8:27 am
Walgreens slashed its 2019 forecast after falling short of expectations in what its CEO described as the most difficult quarter since the company was formed a few years ago. The nation's largest drugstore chain now expects adjusted earnings per share growth to be flat this year, compare to a...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 8:00 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad echoes objections from drugmakers by warning that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of...
Read More
Acting OMB Director Russ Vought speaks during a press briefing at the White House, Monday, March 11, 2019, in Washington. (AP Photo/ Evan Vucci)
March 11, 2019 - 9:41 pm
WASHINGTON (AP) — The Latest on President Donald Trump's proposed 2020 budget (all times local): 9:35 p.m. Hospital groups are objecting strongly to hundreds of billions of dollars in proposed Medicare and Medicaid payment cuts in President Donald Trump's budget. Two major hospital trade groups did...
Read More
House Budget Committee Chair John Yarmuth, D-Ky., walks through the Capitol in Washington, Monday morning March 11, 2019, as President Donald Trump's 2020 budget is delivered to his committee. Trump's new budget calls for billions more for his border wall, with steep cuts in domestic programs but increases for military spending. (AP Photo/J. Scott Applewhite)
March 11, 2019 - 4:51 pm
WASHINGTON (AP) — "Medicare for All" has become catnip for Democratic presidential candidates and many lawmakers, yet Republicans prepping for next year's congressional races are also flocking to it — for entirely different reasons. GOP strategists say they'll use proposals to expand government-run...
Read More
FILE- This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial. (AP Photo/Darron Cummings, File)
March 04, 2019 - 2:32 pm
INDIANAPOLIS (AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain imposed on some patients, but an advocacy group says much bigger changes are needed. The drugmaker said Monday it will introduce a version of the diabetes treatment Humalog that will...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:42 pm
WASHINGTON (AP) — Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday's Senate...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:41 pm
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 1:30 Senators are urging top pharmaceutical executives to help Congress take action against the industry's worst actors who hike prices on once-cheap drugs...
Read More

Pages